ASX - By Stock
|
PYC |
Re:
Ann: RP11 Drug Candidate Progressing to Mid-Stage Human Trials
|
|
76790759
|
14 |
5.2K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
14
|
5.2K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
76790759
|
135 |
49K |
11 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
135
|
49K
|
11
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
76790759
|
257 |
76K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
257
|
76K
|
6
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
76790759
|
1.6K |
785K |
0 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
1.6K
|
785K
|
0
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
76790759
|
1.6K |
785K |
2 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
1.6K
|
785K
|
2
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Shareholder Update
|
|
76790759
|
158 |
63K |
2 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
158
|
63K
|
2
|
|
ASX - By Stock
|
A4N |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
76790759
|
16 |
6.5K |
0 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
16
|
6.5K
|
0
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
76790759
|
1.6K |
785K |
1 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
1.6K
|
785K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Change of Company Name
|
|
76790759
|
9 |
4.6K |
2 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
9
|
4.6K
|
2
|
|
ASX - By Stock
|
5EA |
Re:
Ann: 5EA to Hold Shareholder Call
|
|
76790759
|
44 |
20K |
1 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
44
|
20K
|
1
|
|
ASX - By Stock
|
5EA |
Re:
Ann: 5EA to Hold Shareholder Call
|
|
76790759
|
44 |
20K |
6 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
44
|
20K
|
6
|
|
ASX - By Stock
|
5EA |
Re:
Ann: Trading Halt
|
|
76790759
|
52 |
18K |
0 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
52
|
18K
|
0
|
|
ASX - By Stock
|
5EA |
Re:
Ann: 5EA - EPA Authorization
|
|
76790759
|
1 |
803 |
6 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
1
|
803
|
6
|
|
ASX - By Stock
|
5EA |
Re:
Ann: 5EA to Recapitalize Ahead of First Production
|
|
76790759
|
32 |
14K |
2 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
32
|
14K
|
2
|
|
ASX - By Stock
|
MNS |
Re:
Ann: iM3NY Credit Facility
|
|
76790759
|
459 |
143K |
3 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
459
|
143K
|
3
|
|
ASX - By Stock
|
5EA |
Re:
Ann: 5EA to Recapitalize Ahead of First Production
|
|
76790759
|
32 |
14K |
1 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
32
|
14K
|
1
|
|
ASX - By Stock
|
5EA |
Re:
Ann: 5EA to Recapitalize Ahead of First Production
|
|
76790759
|
32 |
14K |
0 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
32
|
14K
|
0
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Suspension from Official Quotation
|
|
76790759
|
64 |
22K |
5 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
64
|
22K
|
5
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Suspension from Official Quotation
|
|
76790759
|
64 |
22K |
1 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Suspension from Official Quotation
|
|
76790759
|
64 |
22K |
4 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
64
|
22K
|
4
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Suspension from Official Quotation
|
|
76790759
|
64 |
22K |
4 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
64
|
22K
|
4
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
76790759
|
1.6K |
785K |
2 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
1.6K
|
785K
|
2
|
|
ASX - By Stock
|
G1A |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
76790759
|
35 |
10K |
0 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
G1A |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
76790759
|
35 |
10K |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
35
|
10K
|
1
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
76790759
|
1.6K |
785K |
3 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
1.6K
|
785K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 Positive Interim Readout
|
|
76790759
|
34 |
17K |
5 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
34
|
17K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 Positive Interim Readout
|
|
76790759
|
34 |
17K |
14 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
34
|
17K
|
14
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
76790759
|
1.6K |
785K |
2 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
1.6K
|
785K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Trading Halt
|
|
76790759
|
31 |
9.6K |
10 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
31
|
9.6K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
76790759
|
138 |
52K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
138
|
52K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
76790759
|
138 |
52K |
2 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
138
|
52K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
76790759
|
138 |
52K |
2 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
138
|
52K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
76790759
|
138 |
52K |
2 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
138
|
52K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 Positive Interim Readout
|
|
76790759
|
34 |
17K |
5 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
34
|
17K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
76790759
|
138 |
52K |
1 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
138
|
52K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
76790759
|
138 |
52K |
1 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
138
|
52K
|
1
|
|
ASX - By Stock
|
A4N |
Re:
Ann: CFO Appointment
|
|
76790759
|
4 |
1.1K |
0 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
4
|
1.1K
|
0
|
|
ASX - By Stock
|
A4N |
Re:
Ann: CFO Appointment
|
|
76790759
|
4 |
1.1K |
0 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
4
|
1.1K
|
0
|
|
ASX - By Stock
|
A4N |
Re:
Ann: Stage 1 HPA Line nears completion
|
|
76790759
|
26 |
6.6K |
1 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
26
|
6.6K
|
1
|
|
ASX - By Stock
|
MNS |
Re:
MNS threads on HC
|
|
76790759
|
1.9K |
569K |
2 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
1.9K
|
569K
|
2
|
|
ASX - By Stock
|
KAU |
Re:
Ann: Annual Report to shareholders
|
|
76790759
|
12 |
5.1K |
3 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
12
|
5.1K
|
3
|
|
ASX - By Stock
|
5EA |
Re:
Ann: 5EA Commences Step Rate Testing
|
|
76790759
|
5 |
2.9K |
1 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
5
|
2.9K
|
1
|
|
ASX - By Stock
|
5EA |
Re:
Ann: 5EA Commences Step Rate Testing
|
|
76790759
|
5 |
2.9K |
1 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
5
|
2.9K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Presentation - PANDAS/PANS Clinical Trials Results
|
|
76790759
|
9 |
1.9K |
0 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
9
|
1.9K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Presentation - PANDAS/PANS Clinical Trials Results
|
|
76790759
|
9 |
1.9K |
0 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
9
|
1.9K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Presentation - PANDAS/PANS Clinical Trials Results
|
|
76790759
|
9 |
1.9K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
9
|
1.9K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Presentation - PANDAS/PANS Clinical Trials Results
|
|
76790759
|
9 |
1.9K |
0 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
9
|
1.9K
|
0
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
76790759
|
1.6K |
785K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
1.6K
|
785K
|
1
|
|
ASX - By Stock
|
G1A |
Re:
Ann: Positive Operating Cash Flows Achieved for September Quarter
|
|
76790759
|
19 |
8.4K |
0 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
19
|
8.4K
|
0
|
|
ASX - By Stock
|
A4N |
Re:
Ann: HPA First Project Finance Update
|
|
76790759
|
9 |
2.9K |
5 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
9
|
2.9K
|
5
|
|